Yedi Pu

Ibrutinib improves the efficacy of anti‐CD19‐CAR T‐cell therapy in patients with refractory non‐Hodgkin lymphoma

Meijing Liu, Haobin Deng, Juan Mu et al. · Cancer Science · 2021 · 40 citations · Full text

Medicine, Hematology, Oncology +15

Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy

Yifan Zhao, Xiaomei Zhang, Meng Zhang et al. · Annals of Hematology · 2024 · 31 citations

Medicine, Hematology, Oncology +16

The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure

Meng Zhang, Zhao Wang, Jiaxi Wang et al. · Infection and Drug Resistance · 2022 · 25 citations · Full text

Life Sciences, Microbiology, Oncology +17

A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults

Xiaomei Zhang, Hairong Lv, Xia Xiao et al. · Blood · 2023 · 23 citations

Medicine, Hematology, Oncology +16

Metagenomic Next-Generation Sequencing for Diagnostically Challenging Mucormycosis in Patients with Hematological Malignancies

Meng Zhang, Wenyi Lu, Danni Xie et al. · Infection and Drug Resistance · 2022 · 18 citations · Full text

Life Sciences, Microbiology, Oncology +17